Anti-phospholipid antibodies, the causative agent in antiphospholipid syndrome (APS) typically bind to domain I of β2GP1 (29, 30, 31, 32, 33, 34, 35). This evidence concerns the gene APOH and autoimmune polyendocrinopathy.